precision cancer care

NAVICAN is bridging the gap
between testing and treatment.

Because all cancer patients deserve access to the best care.

today s reality

Too many people don’t get the precision therapy they need. We can do better.

infographic-steps infographic-steps

100s of thousands of metastatic cancer patients

infographic-steps infographic-steps

10s of thousands of genomics tests performed annually

Only a small percentage actually receive a change to targeted therapy

Source: 2016 data analysis and primary market research

NAVICAN is the essential bridge to help everyone access precision cancer therapy.
By prioritizing treatment recommendations and streamlining the process, we help oncologists help patients live longer, more fulfilling lives. This way, patients can spend less time worrying about their treatment and have more quality time with those who matter most.

we can help

NAVICAN, an Intermountain Healthcare company, offers TheraMap – a comprehensive end-to-end solution to help both oncologists and patients harness the power of precision genomics, clinical analytics, and patient services for optimal cancer management.

Developed through years of experience and clinical best practices of Intermountain Healthcare, TheraMap gives oncologists more confidence in determining actionable cancer gene mutations. By matching your patient with prioritized treatment options or appropriate clinical trials, we can help you deliver a better outcome and reduce costs.

  • Sample acquisition
    simplifying
    shipment
  • Sequencing & bioinformatics
    testing
  • Molecular tumor board
    guiding
    decisions
  • Therapy access
    navigating
    treatment
  • Follow through
    improving
    outcomes

When TheraMap is ordered by an oncologist, the process starts by securing the tumor specimen for processing. With all the logistics and paperwork taken care of, it’s easier for oncologists to focus on what’s important: caring for their patients.

Utilizing state-of-the-art next-generation sequencing, additional molecular methods, and proprietary data analytics, Precision Genomics at Intermountain Healthcare identifies all clinically relevant cancer mutations. This comprehensive tumor profile serves as the foundation for Intermountain’s molecular tumor board to analyze and prioritize treatment options.

Click here to download the technical details and specific gene list.

Getting results is one thing. Knowing how to interpret them is another. NAVICAN provides access to a group of key opinion leaders and experts in the clinical field with multi-institutional, multi-disciplinary backgrounds. These experts will provide a firm recommendation for treatment with one specific therapy highlighted and others stack ranked below it.

Of course, treatment decisions should always be made by the oncologist and the individual patient, but we can help take much of the uncertainty out of the equation.

While other companies stop at genomic profiling, NAVICAN provides experienced treatment navigators through Intermountain Healthcare to facilitate drug or clinical trial access so that patients can get the precision therapy they need as soon as possible.

Treatment navigators are there every step of the way for both medical staff and patients. They guide the entire process: accessing therapy, taking care of paperwork, submitting insurance claims, and facilitating financial counseling.

We’re committed to caring for patients. Our job isn’t done until we’ve made an impact on each of the patients we serve.

who we are

All patients—not just a few—deserve access to precision cancer care that can lead to better outcomes. The right therapy at the right time will also result in reduced spending for healthcare systems.

Based on proven processes developed through years of experience and clinical best practices of Intermountain Healthcare, NAVICAN was created to transform advances in precision medicine into precision cancer care for patients everywhere that advanced therapies are available.

With TheraMap, expert prioritized therapy recommendations and experienced treatment navigators will simplify the path to drug and clinical trial access. At the same time, we’ll help patients and their caregivers navigate often frustrating administrative processes.

Source: 2016 data analysis and primary market research

we can change lives

We’re driven by an impatience to make more precision therapy options available to more cancer patients. If you have a passion to help people, a desire to grow, and you excel at what you do, join us at NAVICAN to make a positive impact on the world.

connect with us

* Required fields

Your message was sent successfully.

Thank you for visiting Navican

To view the site, please update your browser

The Navican site works on all modern browsers with legacy support back through Internet Explorer 9. Please update by going to the link below.

Update Browser